| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |